Conatus Pharmaceuticals, Inc.. (CNAT) NASDAQ

$0.56 0 (0.00%)

Market Cap: $18.58M

As of 05/26/20 04:00 PM EDT. Market closed.

(CNAT)

Conatus Pharmaceuticals, Inc.. (CNAT) NASDAQ

$0.56 0 (0.00%)

Market Cap: $18.58M

As of 05/26/20 04:00 PM EDT. Market closed.

Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active ... read more

Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. read less

COMPANY PROFILE
Sector
Health Technology
Industry
Biotechnology
CEO
Steven J. Mento
Full Time Employees
6
CEO Compensation (Base)
$521,433
CEO Compensation (Total)
$1.30M
URL
Address
16745 West Bernardo Drive, CA, San Diego, 92127-7619.
Sector
Health Technology
Industry
Biotechnology
CEO
Steven J. Mento
Full Time Employees
6
CEO Compensation (Base)
$521,433
CEO Compensation (Total)
$1.30M
Address
16745 West Bernardo Drive, CA, San Diego, 92127-7619.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$0.23 - $1.07
Volume
0
Avg. Volume (30 days)
2,531,496
Market Cap
$18.58M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
33,170,000
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$0.23 - $1.07
Volume
0
Avg. Volume (30 days)
2,531,496
Market Cap
$18.58M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
33,170,000

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CONATUS PHARMACEUTICALS, INC.
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Pascoe Richard W President, CEO & Director Mar 30, 2021 Buy $1.14 20,000 22,800 30,000 Mar 30, 2021, 06:28 PM
Pascoe Richard W President, CEO & Director Dec 03, 2020 Buy $1.24 10,000 12,394 10,000 Dec 07, 2020, 04:06 PM
Marshall Keith W EVP, COO & CFO May 22, 2020 Option Exercise $0.56 18,615 10,424 19,885 May 27, 2020, 06:09 AM
Spada Alfred P. EVP, R&D and CSO May 22, 2020 Option Exercise $0.56 12,960 7,258 19,595 May 27, 2020, 06:05 AM
Mento Steven J Director May 22, 2020 Option Exercise $0.56 31,428 17,600 39,572 May 27, 2020, 06:04 AM
Smith Edward F III SVP, Reg Affairs and QA Nov 14, 2018 Option Exercise $3.15 1,724 5,431 10,875 Feb 11, 2019, 04:20 PM
Smith Edward F III SVP, Reg Affairs and QA May 14, 2018 Option Exercise $3.31 4,690 15,524 9,151 Feb 11, 2019, 04:20 PM
RIPLEY DANIEL L. SVP, Bus Dev, P&A Mgmt Nov 14, 2018 Option Exercise $3.15 1,861 5,862 32,431 Feb 11, 2019, 04:19 PM
RIPLEY DANIEL L. SVP, Bus Dev, P&A Mgmt May 14, 2018 Option Exercise $3.31 1,290 4,270 30,570 Feb 11, 2019, 04:19 PM
Mento Steven J President, CEO & Director May 04, 2018 Option Exercise $0.99 60,000 59,400 60,000 May 07, 2018, 07:46 PM
Spada Alfred P. EVP, R&D and CSO Feb 27, 2018 Option Exercise $1.24 12,121 15,030 12,121 Mar 01, 2018, 04:08 PM
Smith Edward F III SVP, Reg Affairs and QA Nov 14, 2017 Option Exercise $3.48 4,461 15,524 4,461 Feb 05, 2018, 05:03 PM
RIPLEY DANIEL L. SVP, Bus Dev, P&A Mgmt Nov 14, 2017 Option Exercise $3.48 818 2,847 29,280 Feb 05, 2018, 05:02 PM
RIPLEY DANIEL L. SVP, Bus Dev, P&A Mgmt May 12, 2017 Option Exercise $1.70 761 1,294 28,462 Feb 05, 2018, 05:02 PM
Cashion Charles SVP, Finance, CFO and Sec. Jan 09, 2017 Option Exercise $0.99 42,424 42,000 42,424 Jan 11, 2017, 04:01 PM
Mento Steven J President, CEO & Director Dec 20, 2016 Option Exercise $1.21 41,414 50,091 41,414 Dec 22, 2016, 04:04 PM
Van Wart Harold Director Oct 27, 2016 Option Exercise $0.25 18,181 4,545 18,181 Oct 31, 2016, 04:37 PM
KISNER DANIEL L Director Apr 08, 2015 Buy $5.75 4,000 23,000 7,145 Apr 10, 2015, 04:02 PM
HALE DAVID F Director Jan 08, 2014 Option Exercise $0.99 12,121 12,000 24,242 Jan 10, 2014, 05:07 PM
HALE DAVID F Director Sep 26, 2013 Option Exercise $2.31 12,121 28,000 12,121 Sep 27, 2013, 04:29 PM
Aberdare GP III, L.L.C. 10% Owner Jul 30, 2013 Option Exercise $11.00 10,614 116,754 2,121,992 Aug 01, 2013, 07:18 PM
Aberdare GP III, L.L.C. 10% Owner Jul 30, 2013 Option Exercise $11.00 251 2,761 49,949 Aug 01, 2013, 07:18 PM
Aberdare GP III, L.L.C. 10% Owner Jul 30, 2013 Buy $11.00 2,470 27,170 52,419 Aug 01, 2013, 07:18 PM
Aberdare GP III, L.L.C. 10% Owner Jul 30, 2013 Buy $11.00 104,952 1,154,472 2,226,944 Aug 01, 2013, 07:18 PM
Aberdare GP III, L.L.C. 10% Owner Jul 30, 2013 Sale $11.00 552 6,072 2,111,378 Aug 01, 2013, 07:18 PM
Aberdare GP III, L.L.C. 10% Owner Jul 30, 2013 Sale $11.00 14 154 49,698 Aug 01, 2013, 07:18 PM
Aberdare GP III, L.L.C. 10% Owner Jul 30, 2013 Option Exercise $0.08 73,395 6,055 2,111,930 Aug 01, 2013, 07:18 PM
Aberdare GP III, L.L.C. 10% Owner Jul 30, 2013 Option Exercise $0.08 1,727 142 49,712 Aug 01, 2013, 07:18 PM
Perret Marc Olivier Director Jul 30, 2013 Option Exercise $11.00 16,742 184,162 1,321,795 Aug 01, 2013, 07:18 PM
Perret Marc Olivier Director Jul 30, 2013 Buy $11.00 165,525 1,820,775 1,487,320 Aug 01, 2013, 07:18 PM
Perret Marc Olivier Director Jul 30, 2013 Sale $11.00 352 3,872 1,305,053 Aug 01, 2013, 07:18 PM
Mento Steven J President, CEO & Director Jul 30, 2013 Option Exercise $11.00 1,395 15,345 371,869 Aug 01, 2013, 07:16 PM
Mento Steven J President, CEO & Director Jul 30, 2013 Buy $11.00 13,800 151,800 385,669 Aug 01, 2013, 07:16 PM
KLINGENSTEIN PAUL H Director Jul 30, 2013 Option Exercise $11.00 10,614 116,754 2,121,992 Aug 01, 2013, 07:16 PM
KLINGENSTEIN PAUL H Director Jul 30, 2013 Option Exercise $11.00 251 2,761 49,949 Aug 01, 2013, 07:16 PM
KLINGENSTEIN PAUL H Director Jul 30, 2013 Buy $11.00 2,470 27,170 52,419 Aug 01, 2013, 07:16 PM
KLINGENSTEIN PAUL H Director Jul 30, 2013 Buy $11.00 104,952 1,154,472 2,226,944 Aug 01, 2013, 07:16 PM
KLINGENSTEIN PAUL H Director Jul 30, 2013 Sale $11.00 552 6,072 2,111,378 Aug 01, 2013, 07:16 PM
KLINGENSTEIN PAUL H Director Jul 30, 2013 Sale $11.00 14 154 49,698 Aug 01, 2013, 07:16 PM
KLINGENSTEIN PAUL H Director Jul 30, 2013 Option Exercise $0.08 73,395 6,055 2,111,930 Aug 01, 2013, 07:16 PM
KLINGENSTEIN PAUL H Director Jul 30, 2013 Option Exercise $0.08 1,727 142 49,712 Aug 01, 2013, 07:16 PM
Malik Shahzad Director Jul 30, 2013 Option Exercise $11.00 19,223 211,453 1,976,782 Aug 01, 2013, 07:14 PM
Malik Shahzad Director Jul 30, 2013 Buy $11.00 190,054 2,090,594 2,166,836 Aug 01, 2013, 07:14 PM
Malik Shahzad Director Jul 30, 2013 Sale $11.00 535 5,885 1,957,559 Aug 01, 2013, 07:14 PM
Malik Shahzad Director Jul 30, 2013 Option Exercise $0.08 70,003 5,775 1,958,094 Aug 01, 2013, 07:14 PM
LACASSE LOUIS P Director Jul 30, 2013 Option Exercise $11.00 12,537 137,907 685,937 Aug 01, 2013, 07:12 PM
LACASSE LOUIS P Director Jul 30, 2013 Buy $11.00 123,950 1,363,450 809,887 Aug 01, 2013, 07:12 PM
HALE DAVID F Director Jul 30, 2013 Option Exercise $11.00 261 2,871 141,151 Aug 01, 2013, 07:11 PM
HALE DAVID F Director Jul 30, 2013 Buy $11.00 2,588 28,468 143,739 Aug 01, 2013, 07:11 PM
COOPERATIVE GILDE HEALTHCARE II U.A. 10% Owner Jul 30, 2013 Option Exercise $11.00 16,742 184,162 1,321,795 Aug 01, 2013, 07:10 PM
COOPERATIVE GILDE HEALTHCARE II U.A. 10% Owner Jul 30, 2013 Buy $11.00 165,525 1,820,775 1,487,320 Aug 01, 2013, 07:10 PM
COOPERATIVE GILDE HEALTHCARE II U.A. 10% Owner Jul 30, 2013 Sale $11.00 352 3,872 1,305,053 Aug 01, 2013, 07:10 PM
ADVENT VENTURE PARTNERS LLP 10% Owner Jul 30, 2013 Option Exercise $11.00 19,223 211,453 1,976,782 Aug 01, 2013, 07:09 PM
ADVENT VENTURE PARTNERS LLP 10% Owner Jul 30, 2013 Buy $11.00 190,054 2,090,594 2,166,836 Aug 01, 2013, 07:09 PM
ADVENT VENTURE PARTNERS LLP 10% Owner Jul 30, 2013 Sale $11.00 535 5,885 1,957,559 Aug 01, 2013, 07:09 PM
ADVENT VENTURE PARTNERS LLP 10% Owner Jul 30, 2013 Option Exercise $0.08 70,003 5,775 1,958,094 Aug 01, 2013, 07:09 PM
Scopa James Paul Director Jul 30, 2013 Option Exercise $11.00 16,716 183,876 1,026,815 Aug 01, 2013, 02:21 PM
Scopa James Paul Director Jul 30, 2013 Buy $11.00 165,265 1,817,915 1,192,080 Aug 01, 2013, 02:21 PM
EVNIN LUKE 10% Owner Jul 30, 2013 Option Exercise $11.00 16,716 183,876 1,026,815 Aug 01, 2013, 02:19 PM
EVNIN LUKE 10% Owner Jul 30, 2013 Buy $11.00 165,265 1,817,915 1,192,080 Aug 01, 2013, 02:19 PM
MPM BioVentures IV QP LP 10% Owner Jul 30, 2013 Option Exercise $11.00 16,716 183,876 1,026,815 Aug 01, 2013, 02:18 PM
MPM BioVentures IV QP LP 10% Owner Jul 30, 2013 Buy $11.00 165,265 1,817,915 1,192,080 Aug 01, 2013, 02:18 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Pascoe Richard W President, CEO & Director 03/30/2021 22,800
Pascoe Richard W President, CEO & Director 12/03/2020 12,394
Marshall Keith W EVP, COO & CFO 05/22/2020 10,424
Spada Alfred P. EVP, R&D and CSO 05/22/2020 7,258
Mento Steven J Director 05/22/2020 17,600
Smith Edward F III SVP, Reg Affairs and QA 11/14/2018 5,431
Smith Edward F III SVP, Reg Affairs and QA 05/14/2018 15,524
RIPLEY DANIEL L. SVP, Bus Dev, P&A Mgmt 11/14/2018 5,862
RIPLEY DANIEL L. SVP, Bus Dev, P&A Mgmt 05/14/2018 4,270
Mento Steven J President, CEO & Director 05/04/2018 59,400
Spada Alfred P. EVP, R&D and CSO 02/27/2018 15,030
Smith Edward F III SVP, Reg Affairs and QA 11/14/2017 15,524
RIPLEY DANIEL L. SVP, Bus Dev, P&A Mgmt 11/14/2017 2,847
RIPLEY DANIEL L. SVP, Bus Dev, P&A Mgmt 05/12/2017 1,294
Cashion Charles SVP, Finance, CFO and Sec. 01/09/2017 42,000
Mento Steven J President, CEO & Director 12/20/2016 50,091
Van Wart Harold Director 10/27/2016 4,545
KISNER DANIEL L Director 04/08/2015 23,000
HALE DAVID F Director 01/08/2014 12,000
HALE DAVID F Director 09/26/2013 28,000
Aberdare GP III, L.L.C. 10% Owner 07/30/2013 116,754
Aberdare GP III, L.L.C. 10% Owner 07/30/2013 2,761
Aberdare GP III, L.L.C. 10% Owner 07/30/2013 27,170
Aberdare GP III, L.L.C. 10% Owner 07/30/2013 1,154,472
Aberdare GP III, L.L.C. 10% Owner 07/30/2013 6,072
Aberdare GP III, L.L.C. 10% Owner 07/30/2013 154
Aberdare GP III, L.L.C. 10% Owner 07/30/2013 6,055
Aberdare GP III, L.L.C. 10% Owner 07/30/2013 142
Perret Marc Olivier Director 07/30/2013 184,162
Perret Marc Olivier Director 07/30/2013 1,820,775
Perret Marc Olivier Director 07/30/2013 3,872
Mento Steven J President, CEO & Director 07/30/2013 15,345
Mento Steven J President, CEO & Director 07/30/2013 151,800
KLINGENSTEIN PAUL H Director 07/30/2013 116,754
KLINGENSTEIN PAUL H Director 07/30/2013 2,761
KLINGENSTEIN PAUL H Director 07/30/2013 27,170
KLINGENSTEIN PAUL H Director 07/30/2013 1,154,472
KLINGENSTEIN PAUL H Director 07/30/2013 6,072
KLINGENSTEIN PAUL H Director 07/30/2013 154
KLINGENSTEIN PAUL H Director 07/30/2013 6,055
KLINGENSTEIN PAUL H Director 07/30/2013 142
Malik Shahzad Director 07/30/2013 211,453
Malik Shahzad Director 07/30/2013 2,090,594
Malik Shahzad Director 07/30/2013 5,885
Malik Shahzad Director 07/30/2013 5,775
LACASSE LOUIS P Director 07/30/2013 137,907
LACASSE LOUIS P Director 07/30/2013 1,363,450
HALE DAVID F Director 07/30/2013 2,871
HALE DAVID F Director 07/30/2013 28,468
COOPERATIVE GILDE HEALTHCARE II U.A. 10% Owner 07/30/2013 184,162
COOPERATIVE GILDE HEALTHCARE II U.A. 10% Owner 07/30/2013 1,820,775
COOPERATIVE GILDE HEALTHCARE II U.A. 10% Owner 07/30/2013 3,872
ADVENT VENTURE PARTNERS LLP 10% Owner 07/30/2013 211,453
ADVENT VENTURE PARTNERS LLP 10% Owner 07/30/2013 2,090,594
ADVENT VENTURE PARTNERS LLP 10% Owner 07/30/2013 5,885
ADVENT VENTURE PARTNERS LLP 10% Owner 07/30/2013 5,775
Scopa James Paul Director 07/30/2013 183,876
Scopa James Paul Director 07/30/2013 1,817,915
EVNIN LUKE 10% Owner 07/30/2013 183,876
EVNIN LUKE 10% Owner 07/30/2013 1,817,915
MPM BioVentures IV QP LP 10% Owner 07/30/2013 183,876
MPM BioVentures IV QP LP 10% Owner 07/30/2013 1,817,915
Load More Insider Transactions